Patent ID: 7384962

Claim:
A compound of general Formula (I) wherein: R 1 , R 2 and R 3 may be the same or different and are independently selected for each occurrence from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted heteroarylalkyl, nitro, —OH, cyano, formyl, acetyl, halogen, a protecting group, —C(O)—R a , —C(O)O—R a , —C(O)NR a R a , —S(O) q —R a , —S(O) q —NR a R a , —NR a R a , —OR a , and —SR a , or when two R 3 substitutents are ortho to each other, they may be joined to a form a saturated or unsaturated 3-7 membered ring, which may optionally include up to two heteroatoms which may be the same or different selected from O, NR a or S; R 4 is —NR 5 R 6 , with the proviso that R 4 is not NH 2 ; R 5 and R 6 may be the same or different and are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted heteroarylalkyl, nitro, —OH, cyano, halogen, —C(O)—R a , —C(O)O—R a , —C(O)NR a R a , —S(O) q —R a , —S(O) q —NR a R a , —C(═NR a )—R a , —C(═NR a )—NR a R a , —C(═S)—NR a R a , —C(═S)—R a , —N═C(R a R a ), —NR a R a , —OR a , —SR a , and a protecting group or when R 5 and R 6 are ortho to each other, they may be joined to a form a saturated or unsaturated 3-7 membered cyclic ring, which may optionally include up to two heteroatoms which may be the same or different selected from O, NR a or S; Ar is selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl ring; X is NR a ; Y is selected from the group consisting of —C(O)NR 7 ; R 7 is selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, and hydroxyl; P is selected from the group consisting of O and S; m is 0-3; n is 1-4; q is 0, 1 or 2; R a is selected from the group consisting of hydrogen or substituted or unsubstituted alkyl; or a tautomer thereof, a regioisomer thereof, a stereoisomer thereof, an enantiomer thereof, a diastereomer thereof, a pharmaceutically acceptable salt thereof, an N-oxide thereof, or a pharmaceutically acceptable solvate thereof.